Ex Vivo Anti-CD3 Antibody-Activated Donor T Cells Have a Reduced Ability to Cause Lethal Murine Graft-Versus-Host Disease but Retain Their Ability to Facilitate Alloengraftment

Article

T Cells Tolerized Ex Vivo to Host Alloantigen by Anti-CD40 Ligand (CD40L:CD154) Antibody Lose Their Graft-Versus-Host Disease Lethality Capacity but Retain Nominal Antigen Responses

CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses.

Article

Protection from lethal murine graft-versus-host disease without compromise of alloengraftment using transgenic donor T cells expressing a thymidine kinase suicide gene.

Article

Lethal murine graft-versus-host disease induced by donor?/s expressing t cells with specificity for host nonclassical major histocompatibility complex class ib antigens.

FTY720 Markedly Increases Alloengraftment But Does Not Eliminate Host Anti-Donor T Cells That Cause Graft Rejection Upon Its Withdrawal

Article

Protection from lethal murine graft-versus-host disease without compromise of alloengraftment using transgenic donor T cells expressing a thymidine kinase suicide gene

Article

In vivo – activated CD 103 CD 4 regulatory T cells ameliorate ongoing chronic graft-versus-host disease

Article

Dendritic cell–activated CD44hiCD8+ T cells are defective in mediating acute graft-versus-host disease but retain graft-versus-leukemia activity

Article